3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
4
Gynecologic
2
Sarcoma
1
Gastrointestinal
1
Conditions
Sarcoma, Ewing
1
Interventions
Specimen Handling
14
Magnetic Resonance Spectroscopy
14
Cyclophosphamide
10
Doxorubicin
8
Biopsy
8
atezolizumab
7
X-Rays
7
Radiation
7
Temozolomide
6
Nivolumab
6
fludarabine
5
Vincristine
5
Radiotherapy
5
Phantoms, Imaging
5
Etoposide
5
Bevacizumab
5
pembrolizumab
4
cabozantinib
4
anlotinib
4
Sirolimus
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Immunoglobulin G
4
Ifosfamide
4
Disulfides
4
palbociclib
3
olaparib
3
liposomal doxorubicin
3
fludarabine phosphate
3
Surgical Procedures, Operative
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Dose Hypofractionation
×
Sarcoma
×
30 days
×
Clear all
NCT07188532
2026-06-04
BEAR
Mayo Clinic
Phase NA
Recruiting
141 enrolled